Cargando…
Cell Type Preference of a Novel Human Derived Cell-Permeable Peptide dNP2 and TAT in Murine Splenic Immune Cells
Cell-permeable peptides (CPPs) have been widely studied as an attractive drug delivery system to deliver therapeutic macromolecules such as DNA, RNA, and protein into cells. However, its clinical application is still limited and controversial due to the lack of a complete understanding of delivery e...
Autores principales: | Lim, Sangho, Lee, Jung-ah, Koo, Ja-Hyun, Kang, Tae Gun, Ha, Sang-Jun, Choi, Je-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871486/ https://www.ncbi.nlm.nih.gov/pubmed/27186978 http://dx.doi.org/10.1371/journal.pone.0155689 |
Ejemplares similares
-
dNP2 is a blood–brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis
por: Lim, Sangho, et al.
Publicado: (2015) -
LRR domain of NLRX1 protein delivery by dNP2 inhibits T cell functions and alleviates autoimmune encephalomyelitis
por: Koo, Ja-Hyun, et al.
Publicado: (2020) -
dNP2-ctCTLA-4 inhibits German cockroach extract-induced allergic airway inflammation and hyper-responsiveness via inhibition of Th2 responses
por: Lim, Sangho, et al.
Publicado: (2017) -
NFAT-Specific Inhibition by dNP2-VIVIT Ameliorates Autoimmune Encephalomyelitis by Regulation of Th1 and Th17
por: Lee, Hong-Gyun, et al.
Publicado: (2019) -
Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma
por: Ono, Sawako, et al.
Publicado: (2019)